Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of azacitidine freeze-dried preparation and preparation method thereof

A technology for azacitidine and freeze-dried preparations, applied in the field of azacitidine freeze-dried preparations and preparations, can solve the problems of unsatisfactory, high residual, large amount of organic solvents, etc., and achieve the reduction of product-related substances and physical and chemical stability Good performance and low amount of organic solvent

Active Publication Date: 2018-02-13
QILU PHARMA HAINAN
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] US2011 / 0042247 A1 discloses a preparation method of azacitidine freeze-dried preparation. During the sample preparation process according to Example 1, it is found that the dissolution rate of raw materials is slow, the batching time is long, and the hydrolyzed impurities are relatively high, resulting in the production of related substances in the product. Larger, not conducive to product quality assurance
[0011] CN 103251564 A discloses azacitidine for injection and its preparation method. The measure of adjusting the pH of the solution is used to slow down the hydrolysis rate of the raw material. However, since the hydrolysis rate of this product is less affected by the pH, it slows down the hydrolysis rate of the raw material by controlling the pH of the solution. Hydrolysis is not ideal
[0012] WO 2013 / 012135 A1 discloses a preparation method of azacitidine freeze-dried preparation. The batching process adopts the method of directly dissolving azacitidine in 40%-60% tert-butanol aqueous solution, because azacitidine is in tert-butanol Insoluble in butanol, the dissolution rate of raw materials in the mixed solution is slow, resulting in slow batching speed and long time; and the amount of organic solvent is large, so the dissolved raw materials are easy to recrystallize and precipitate; tert-butanol is an organic solvent with a high boiling point, which is not easy Removed by freeze-drying, the final residue in the preparation is relatively high, and tert-butanol is not a low-toxic organic solvent specified in the 2010 edition of the "Chinese Pharmacopoeia", and product safety cannot be guaranteed; a large number of organic solvents pollute the environment and equipment. Not conducive to scale-up production
[0013] At present, the common problems in the preparation process of azacitidine powder injection are: 1. The raw materials are easily hydrolyzed and are insoluble drugs. The raw materials dissolve slowly, and the batching time is long, resulting in hydrolyzed impurities, which is not conducive to product quality assurance; 2. 1. Add additional auxiliary materials to improve the stability of the feed liquid and improve product quality, but the effect is not ideal; 3. To improve the stability of the feed liquid, a large amount of high-boiling organic solvents are added to the feed liquid, which is not conducive to industrial scale-up production and environmental protection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of azacitidine freeze-dried preparation and preparation method thereof
  • A kind of azacitidine freeze-dried preparation and preparation method thereof
  • A kind of azacitidine freeze-dried preparation and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039]Measure 950ml of water for injection, cool to -3~-1℃, weigh 5g of mannitol and dissolve it in the above water for injection, weigh 5g of azacitidine, stir and disperse azacitidine into 20ml of ethanol, and dissolve azacitidine After mixing and dissolving the cytidine ethanol dispersion and water for injection, add water to 1000ml, stir the material liquid evenly and filter it with a 0.22μm microporous membrane. The filtered solution is divided into glass bottles, 20ml / bottle, and freeze-dried to obtain azacitidine freeze-dried powder.

Embodiment 2

[0041] Measure 950ml of water for injection, cool to -3~-1℃, weigh 5g of mannitol and dissolve it in the above water for injection, weigh 5g of azacitidine, stir and disperse azacitidine into 20ml of isopropanol, After mixing and dissolving the isopropanol dispersion of azacitidine and water for injection, add water to 1000ml, stir the material evenly and filter it with a 0.22μm microporous membrane. The filtered solution is divided into glass bottles, 20ml / bottle, and freeze-dried Azacitidine freeze-dried powder was obtained.

Embodiment 3

[0043] Measure 950ml of water for injection, cool to -3~-1°C, weigh 5g of mannitol and dissolve it in the above water for injection, weigh 5g of azacitidine, stir and disperse azacitidine into 20ml of methanol, and dissolve azacitidine After the methanol dispersion of cytidine and water for injection are mixed and dissolved, add water to 1000ml, stir the material liquid evenly, filter it with a 0.22μm microporous membrane, pack the filtered solution into glass bottles, 20ml / bottle, and freeze-dry to obtain Azacella Glycoside freeze-dried powder.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of pharmaceutical preparations and in particular relates to an azacitidine freeze-dried preparation with stable proprieties. The active ingredient of the azacitidine freeze-dried preparation is a treatment effective amount of azacitidine; a solution contains an organic solvent, a freeze-drying proppant and injection water before freeze-drying; the organic solvent is selected from ethanol, isopropanol, methanol or a mixed solution thereof in any ratio, and preferably is ethanol; and the usage amount of the organic solvent is 0.3-6.0% of the total volume of the solution before freeze-drying. The invention also provides a preparation method of the azacitidine freeze-dried preparation which is simple in process, is suitable for scale production and can be clinically used.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations. Specifically relates to a lyophilized preparation of azacitidine and a preparation method thereof. Background technique [0002] Azacitidine (Azacitidine) is a DNA methyltransferase inhibitor that can cause DNA hypomethylation and has direct cytotoxicity. In May 2004, the U.S. FDA approved the listing of the lyophilized preparation Vidaza for bone marrow Treatment of all subtypes of dysplastic syndromes. [0003] The structural formula of azacitidine is as follows: [0004] [0005] Azacitidine (compound 1) is a cytidine nucleoside analogue, which is easily hydrolyzed in water and mainly produces two hydrolyzed products, which are the main impurities of azacitidine for injection. As shown in the following reaction, the nitrogen-containing heterocycle of azacitidine is first opened to obtain compound 2 (RGU-CHO). This step is a reversible reaction. Compound 2 is further h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/706A61K9/19A61K47/10A61K47/26A61P7/00A61P7/06
Inventor 杨清敏郑威威刘宝明张明会
Owner QILU PHARMA HAINAN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products